Related by context. All words. (Click for frequent words.) 69 Aliskiren 67 Meets Primary Endpoint 67 Oral Mucositis 67 Transdermal Delivery 67 Initiates Clinical 67 RNAi Therapeutic 67 Diabetic Foot Ulcer 67 Novel Antibiotic 67 Disease Progression 67 Anticancer Agent 66 TB Vaccine 66 Phase III Clinical Trial 66 Drug Candidate 66 Systemic Delivery 66 Novel Therapeutic 66 Prolongs Survival 66 Tuberculosis Vaccine 66 Clinical Outcome 66 Demonstrates Significant 66 JAK Inhibitor 66 Seasonal Influenza Vaccine 65 Achieves Primary Endpoint 65 Osteoporosis Treatment 65 Initiate Clinical Trial 65 Phase 2b Clinical Trial 65 Antibody Discovery 65 Pulmonary Arterial Hypertension 65 Investigational Compound 65 Therapeutic Antibody 65 Monoclonal Antibody 65 Investigational Drug 65 Files IND 65 Treating Chronic 65 RNAi Therapeutics 65 Cardiotoxicity 64 Patient Enrollment 64 Preclinical Data 64 Human Antibody 64 Oral Fingolimod 64 Tyrosine Kinase Inhibitor 64 Antitumor Activity 64 Protease Inhibitor 64 Hypercholesterolemia 64 Significantly Improves 64 Demonstrates Efficacy 64 Fibrinogen 64 Clinical Trial Evaluating 64 Atopic Dermatitis 64 Combination Therapy 64 Investigational Treatment 64 Nilotinib 64 Receptor Agonist 64 Initiates Clinical Trial 64 Hsp# Inhibitor 64 Uric Acid 64 Shows Promise Against 64 Oral Formulation 64 Novel Mechanism 64 Kinase Inhibitor 64 Synthetic Peptide 63 Nanoemulsion 63 Phase III Trial 63 Phase IIa Trial 63 Respiratory Virus 63 JAK2 Inhibitor 63 Transdermal Patch 63 Platelet Function 63 Gastric Cancer 63 Antibody Drug Conjugate 63 Protein Interactions 63 Presents Preclinical Data 63 uricase 63 Hepatic Encephalopathy 63 First Patient Treated 63 Receives Orphan Drug Designation 63 Unfractionated Heparin 63 Phase 2b Trial 63 Invasive Fungal Infections 63 Submits NDA 63 Adult Stem Cell Therapy 63 Tumor Targeting 63 Inhaled Nitric Oxide 63 Pharmacokinetic Study 63 Gout Drug 63 Initiates Clinical Trials 63 Shows Promising 63 Kidney Function 63 Cannabinoid 63 oral renin inhibitor 63 Acute Ischemic Stroke 63 Therapeutic Protein 63 See CLINICAL PHARMACOLOGY 63 Phase 2b Study 63 Antisense Drug 63 Skeletal Muscle 63 FDA Okays 63 Drug Shows Promise 63 Heart Transplant Recipients 63 Severe Sepsis 63 Initiates Phase III 63 Lymphoid 63 Dendritic Cells 63 Topical Treatment 63 Inflammatory Markers 62 Protein Expression 62 Fondaparinux 62 Demonstrates Potential 62 Improves Outcomes 62 Osteoporosis Drug 62 Novel Compound 62 Clinical Trial Results 62 Phase 1b Clinical Trial 62 Cinacalcet 62 Therapy Reduces 62 Therapeutic Vaccine 62 Diabetic Neuropathy 62 Visceral Fat 62 Initiates Phase II 62 Peripheral Arterial 62 Novel Oral 62 Patients Treated With 62 Severe Asthma 62 Advanced Melanoma 62 Symptom Relief 62 Mycophenolate Mofetil 62 Vaccine Adjuvant 62 Demonstrates Ability 62 Carotid Stenting 62 Insulin Resistance 62 Granted Orphan Drug 62 Erythropoietic 62 FDA Accepts 62 Laryngeal Cancer 62 Study Demonstrates 62 Vaccine Candidate 62 Anti Inflammatory Drug 62 Oral Spray 62 Minimally Invasive Treatment 62 Fracture Risk 62 Single Dose 62 Renal Cell Carcinoma 62 Infected Patients 62 Stem Cell Treatment 62 Combo Therapy 62 Resistant Hypertension 62 Phase 2a Trial 62 Protease Inhibitors 62 Is Well Tolerated 62 Presents Preclinical 62 Rheumatoid Arthritis Drug 62 Safinamide 62 Dose Escalation 62 HCV Protease Inhibitor 62 Blinatumomab 62 Antiviral Therapy 62 Therapeutic Antibodies 62 Allergic Rhinitis 62 Male Contraceptive 62 Initiates Phase 2b 62 Significantly Improved 62 Aptamer 62 FDA Approvals 62 Preclinical Study 62 Inhaled Corticosteroids 62 Postmenopausal Osteoporosis 62 Pharmaceuticals Initiates 62 Immunosuppression 62 Neoadjuvant Chemotherapy 62 Interferon Gamma 62 Interferon Beta 62 Circulating Tumor Cells 61 Completes Patient Enrollment 61 Treated Patients 61 Develop Novel 61 Schizophrenia Treatment 61 Therapeutic Potential 61 Schizophrenia Drug 61 Endovascular Treatment 61 Benign Prostatic Hyperplasia 61 Coronary Arteries 61 Chronic Heart Failure 61 Successfully Completes Phase 61 Attenuates 61 Therapy Shows Promise 61 Cancer Stem Cells 61 Drug Resistant 61 Adjuvant Treatment 61 Fungal Infections 61 First Patient Enrolled 61 Improves Survival 61 Phase IIb Clinical Trial 61 Patient Outcomes 61 Demonstrates Positive 61 Anti Tumor Activity 61 FDA Clears 61 Study Evaluating 61 Anticoagulation 61 Novel Inhibitor 61 Recombinant Human 61 Mouse Model 61 Prostate Cancer Vaccine 61 Breast Cancer Recurrence 61 Lupus Drug 61 Phase 2a Clinical Trial 61 Insulin Sensitivity 61 BAL# [002] 61 Sequencing Systems 61 Testosterone Patch 61 Renal Cancer 61 Blood Pressure Drug 61 Autoimmune Disease 61 Hepatocellular Carcinoma 61 Acute Heart Failure 61 Phase IIb Trial 61 Pegylated Liposomal Doxorubicin 61 Pazopanib 61 Allogeneic 61 Percutaneous Tibial Nerve Stimulation 61 Antitumor 61 Acute Pain 61 Small Molecule 61 Insulin Therapy 61 Chronic Hepatitis C 61 Glatiramer Acetate 61 Hematopoietic 61 Artificial Cornea 61 Malaria Vaccine 61 Mitral Valve Repair 61 Rheumatoid Arthritis Patients 61 Image Guided 61 Bosutinib 61 Virus Infection 61 Efficacy Trial 61 Hematological Cancers 61 DNA Methylation 61 Vascular Inflammation 61 Dehydrogenase 61 Stent Thrombosis 61 Vicriviroc 61 Phase Ib Clinical Trial 61 Anticancer Activity 61 Somatostatin 61 Lubiprostone 61 Universal Flu Vaccine 61 Treatment Naive Patients 61 SUTENT ® 61 Ischemic 61 Immunotherapeutic 61 Anticancer Drug 61 Combination Treatment 61 Antithrombin 61 Telbivudine 60 Autologous Stem Cell Transplantation 60 Neural Stem Cell 60 Factor Xa Inhibitor 60 Secondary Hyperparathyroidism 60 cinacalcet 60 Fatty Liver 60 Protein Therapeutics 60 Humanized Anti 60 Immunosuppressant 60 Genetic Variation 60 Teriparatide 60 Receives Marketing Authorization 60 Pooled Analysis 60 Sipuleucel T 60 Shows Efficacy 60 Biphasic 60 Bucindolol 60 Squalamine 60 Bone Metastases 60 Complicated Skin 60 Contrast Agent 60 Tumor Necrosis Factor 60 Naive Patients 60 Embolic 60 Replacement Therapy 60 Hypertensive Patients 60 Microbicide 60 Initiate Phase III 60 Oral Insulin 60 Smooth Muscle 60 Decitabine 60 Left Atrial 60 Multicenter Randomized 60 Chronic Hepatitis B 60 Factor Receptor 60 Clinical Evaluation 60 Lung Cancer Survival 60 Hospital Acquired Pneumonia 60 Hepatitis C Virus HCV 60 Bosentan 60 Receives Milestone Payment 60 Low Dose 60 Sevelamer 60 Interferon Alpha 60 Antiviral Activity 60 Adjuvant Therapy 60 Dose Escalation Study 60 Bioavailability 60 Initiates Enrollment 60 Presents Positive 60 Efficacious 60 Polymerase Inhibitor 60 Randomized Study 60 Pivotal Study 60 Bone Marrow Transplants 60 HER2 Positive Breast Cancer 60 IND Filing 60 Cancer Vaccines 60 Cellular Immunotherapy 60 Brain Metastases 60 Rotavirus Vaccine 60 Therapeutic Efficacy 60 Stakeholder Opinions 60 Monotherapy 60 Bone Marrow Stem Cells 60 Melphalan 60 Sitagliptin 60 Breast Cancer Treatment 60 Lung Injury 60 Announces FDA Clearance 60 Dasatinib 60 Lung Cancer Trial 60 Pertuzumab 60 Phase IIa Clinical Trial 60 Aurora Kinase 60 First Patient Dosed 60 Confirms Efficacy 60 Elagolix 60 Regenerative Cells 60 Overactive Bladder 60 Renal Artery 60 Ebola Vaccine 60 Pafuramidine 60 Confirmatory Phase 60 IND Application 60 Less Invasive 60 Ozarelix 60 Cancer Therapies 60 Extracellular Matrix 60 Psoriasis Drug 60 Adjuvant Chemotherapy 60 Fixed Dose Combination 60 Electroporation 60 Lung Cancer Drug 60 Stent Coating 60 Preclinical Models 60 Improves Quality 60 Investigational Agent 60 Antiplatelet 60 Hepatitis C Virus 60 Tezampanel 60 Statistically Significant 60 Initiate Phase 60 Further Validates 60 Anti Tumor 60 Initiates Dosing 60 Risk Stratification 60 Reduced Risk 60 Well Tolerated 60 Myeloperoxidase 60 Antigen Specific 60 Inhaled Liposomal Ciprofloxacin 60 Drug Combo 60 Stent Restenosis 60 Tiotropium 60 Macrolide 60 Eluting Stent 60 Appears Safe 60 DiLA2 60 Pivotal Trial 60 Treatment Regimen 60 Protein Biomarker 60 Antimicrobial Coating 60 Double Blind Randomized 60 Diabetic Patients 60 Vidofludimus 60 Venous Thromboembolism 60 Treatment Reduces 60 Recurrent Breast Cancer 60 Cardiomyocytes 60 Myocardial Perfusion Imaging 60 Anticoagulant 60 Prospective Randomized 60 Demonstrates Improved 60 Metabolic Endocrinology 60 Multiple Myeloma Patients 60 Tesamorelin 60 Diagnostic Tools 60 Advanced Renal Cell 60 Hormone Therapy 60 Therapy Improves 60 Zysolin TM 60 Signaling Pathway 60 Enzyme Replacement Therapy 59 Glufosfamide 59 Patent Covering 59 MEK Inhibitor 59 proprietary PEGylation 59 Skin Lesions 59 Epoetin 59 Therapy Evaluation 59 Inhaled Insulin 59 Anti CD# Antibody 59 Metabolic Disease 59 Trial Evaluating 59 Clinical Study 59 Randomized Clinical Trial 59 Quantitation 59 Demonstrates Potent 59 Novel Method 59 Patients Suffering 59 Tumor Growth 59 Angiogenic 59 Leukemia Cells 59 Study Showed 59 Placebo Controlled Trial 59 Improve Survival 59 Liprotamase 59 Interferon Alfa 59 Myelodysplastic Syndromes 59 Experimental Vaccine 59 Gets FDA Clearance 59 Molecular Diagnostic Test 59 Hemopurifier ® 59 Anticalins ® 59 Improved Survival 59 humanized monoclonal 59 Present Preclinical Data 59 Maven Semantic 59 Newly Diagnosed Multiple Myeloma 59 Antiretroviral 59 Receptor Antagonists 59 Teva Provides Update 59 ST Elevation Myocardial 59 Toxicogenomics 59 Meta Analysis 59 EntreMed Presents 59 Breast Cancer Cells 59 Bacteremia 59 Progenitor Cells 59 Sapacitabine 59 Therapeutic Effects 59 Molecular Diagnostic 59 Viral Load 59 Vertebral Fracture 59 Reports Preclinical Data 59 Transcription Factor 59 Protein Involved 59 Microplasmin 59 Autoimmune Diseases 59 PEGylated anti 59 Diabetic Nephropathy 59 Node Positive 59 Biosynthesis 59 Clinically Significant 59 Completes Enrollment 59 Proves Effective 59 Integrase Inhibitor 59 Etravirine 59 Advanced Prostate Cancer 59 Relapsing Multiple Sclerosis 59 Patient Enrolment 59 Radiofrequency Ablation RFA 59 Metastatic Melanoma 59 Transferrin 59 Multidrug Resistant 59 Demonstrates Sustained 59 Radiation Induced 59 Antiepileptic Drug 59 Genedata Expressionist 59 Castration Resistant Prostate Cancer 59 Saquinavir 59 Knee Osteoarthritis 59 Cardiovascular Events 59 Immunomedics Announces 59 Long Term Efficacy 59 Cholesterol Lowering Drug 59 Ovarian Cancer Treatment 59 Obese Patients 59 Pharmacokinetics PK 59 Personalised Medicine 59 Avian Flu Vaccine 59 Test Detects 59 Clinical Trial Enrollment 59 Myocardial Ischemia 59 Plaque Psoriasis 59 Assay Kits 59 Protein Linked 59 Controlled Study 59 Novel Protein 59 Chemoradiation 59 Genes Involved 59 Pandemic Influenza Vaccines 59 Prognostic Value 59 candidate TNFerade biologic 59 BiTE Antibody 59 Fabry Disease 59 Shown Effective 59 Hepatitis C Treatment 59 Cardiometabolic 59 Tigecycline 59 Tumor Response 59 Predictive Toxicology 59 Clinical Trial Data 59 Antibacterials 59 Trodusquemine MSI 59 Gastrointestinal Disorders 59 Commercialize Novel 59 Adjunctive Therapy 59 Phase 2a Study 59 Carotid Artery Stenting 59 Osteoarthritis Patients 59 Acute Stroke 59 peptide conjugated 59 Heart Failure Patients 59 Inhibitor Human 59 Thyroid Hormone 59 Patients Treated 59 Improve Outcomes 59 Immunostimulatory 59 Pandemic Influenza Vaccine 59 acetonide FA 59 Epilepsy Drug 59 Demonstrated Significant 59 Nicotine Vaccine 59 Insulin Delivery 58 Glycosylation 58 Hormone Refractory Prostate Cancer 58 Nerve Regeneration 58 Metastatic Prostate Cancer 58 Breast Ultrasound 58 Patients Undergoing 58 Carboplatin Paclitaxel 58 Toxicity Testing 58 Beta Blocker 58 Statin Therapy 58 Subgroup Analysis 58 Versus Placebo 58 Study Evaluates 58 Solid Tumors 58 Proven Effective 58 GIPET 58 Liver Cancer 58 Degarelix 58 Civacir 58 Study Casts Doubt 58 Cytotoxic 58 Breast Tumor 58 von Willebrand Factor 58 Vaginal Gel 58 Disease Modifying 58 Inhibits 58 Denufosol 58 Generic Version 58 TNF Tumor Necrosis Factor 58 Ischemic Stroke 58 Therapeutic Vaccines 58 Treating Depression 58 Combination REOLYSIN R 58 Testosterone Gel 58 Oligonucleotides 58 Dupuytren Contracture 58 Contrast Enhanced 58 Clinical Efficacy 58 Urinary Incontinence 58 Sirolimus Eluting Stent 58 Pivotal Phase III 58 Oncolytic 58 Differentially 58 HDAC Inhibitor 58 Aneurysm Repair 58 Kinase Inhibitors 58 Relapsed Multiple Myeloma 58 Vascular Grafts 58 Non Inferiority 58 Breast Tumors 58 Gamunex C 58 Intravenous Formulation 58 Intraocular Pressure 58 Prophylactic Treatment 58 Effectively Treats 58 Receives CE Marking 58 PKC# 58 Successfully Treated 58 Submits IND 58 Treating Heart Failure 58 Fc fusion protein 58 Receives Positive Opinion 58 Cell Transplant 58 Survival Benefit 58 Retreatment 58 Receives Orphan Drug 58 Golimumab 58 Phase III Pivotal 58 Begins Dosing 58 Earns Milestone Payment 58 Statin Drugs 58 Left Ventricular 58 Receives Approvable Letter 58 Diamyd Medical Diamyd 58 Lowers Risk 58 rxRNA 58 Trobalt 58 Pivotal Phase 58 Adjuvanted 58 FS Antihemophilic Factor Recombinant 58 Neuroprotection 58 Antiangiogenic 58 Recombinant Protein 58 FVIIa 58 Metastatic Colorectal Cancer 58 Immune Therapy 58 eFlow R 58 Newly Diagnosed 58 Post Operative 58 MKC# MKC# PP 58 Islet Transplantation 58 Advanced Pancreatic Cancer 58 Tablet Formulation 58 Study Shows Benefits 58 Cardiovascular Outcomes 58 Pharmacogenomic 58 Wound Dressing 58 Inflammatory Arthritis 58 Synerx Pharma 58 Cervical Dysplasia 58 Patients Receiving 58 Dose Response 58 NDA Submission 58 Medullary Thyroid Cancer 58 Anti Angiogenesis 58 Previously Treated 58 Biomarker Study 58 Shows Promise 58 PEGylated interferon 58 Lymphatic System 58 Systemic Sclerosis 58 Receives Complete Response 58 Calcium Acetate 58 Generic Versions 58 Peripheral Arterial Disease 58 Isis Pharma 58 Diastolic Heart Failure 58 Home Hemodialysis 58 Dose Ranging 58 Mesenchymal Stem Cells 58 Non Invasive Treatment 58 Placebo Controlled Study 58 Jerini Ophthalmic 58 Calcitonin 58 Liver Toxicity 58 HER2 Positive 58 Radiofrequency Ablation 58 Blood Clotting 58 Embolization 58 Enlarged Prostate 58 PICM 58 Bazedoxifene 58 busulfan 58 Prostate Cancer Treatment 58 Fibromyalgia Pain 58 Analytical Tool 58 Secretase 58 Liver Transplant Patients 58 Initiate Phase II 58 Clinical Outcomes 58 Begin Clinical Trials 58 Nucleic Acids 58 Lauriad 58 Confocal Microscopy 58 Investigational Oral 58 Inhalation Solution 58 Innate Immune 58 Treatment Shows Promise 58 ARIXTRA R 58 Taxane 58 novel oral anticoagulant 58 Cell Transplants 58 Growth Hormone Deficiency 58 topically applied SEPA 57 Pneumonia Vaccine 57 Progenitor Cell 57 Randomized Evaluation 57 Artificial Pancreas 57 Portal Hypertension 57 Platelet Inhibition 57 Collaborators Publish 57 Gefitinib 57 Asthma Treatment 57 Neuroendocrine Tumors 57 Pandemic Flu Vaccine 57 Bioartificial Liver 57 NMDA Receptor 57 Metastatic Renal Cell Carcinoma 57 Phase III Clinical Trials 57 DXL TM 57 Kidney Transplant Patients 57 metastatic neuroendocrine tumors 57 Analyte 57 Gene Variation 57 Slows Progression 57 Immunomodulatory 57 Myeloma Patients 57 Milestone Payment 57 Drug Eluting 57 Archexin 57 Cell Adhesion 57 Immune Mediated 57 Non Invasive 57 Epithelial Cell 57 Renal Cell Cancer 57 monoclonal antibody MAb 57 Sanvar R 57 Bendamustine 57 Multicenter Trial 57 Drug Absorption 57 Telaprevir VX 57 Potent Inhibitor 57 Hepatocytes 57 Phase III Trials 57 anti CD3 57 Cutaneous T 57 systemic immunosuppressive drugs 57 II Clinical Trial 57 VIVUS Qnexa 57 Plasmin 57 Cell Lymphoma 57 EGIR 57 Heparins 57 Ovarian Cancer Patients 57 Activity Assay 57 ProFibrix 57 Predict Risk 57 Reduces Risk 57 Nymox NX 57 FOLOTYN ® 57 Reperfusion Injury 57 Prostate Biopsy 57 Hematological Malignancies 57 Late Breaker 57 Ambrisentan 57 Superoxide 57 Intravail ® 57 Alferon N 57 Treatment Naïve 57 Lung Tumors 57 Vaccine Shows Promise 57 RNA Interference 57 Thrombin 57 Microfluidic Device 57 Orally administered 57 Protein Synthesis 57 Previously Untreated 57 Phase III Pivotal Trial 57 Unresectable 57 Blood Pressure Lowering 57 Cardiac Rhythm 57 AdVac R 57 Adverse Event 57 Inflammatory Diseases 57 Randomized Trials 57 Expanded Indication 57 Presents Positive Preclinical 57 Drug Coated Stents 57 Unstable Angina 57 platinum chemotherapeutic 57 Gamunex Immune Globulin Intravenous 57 Announce Collaboration Agreement 57 Liver Fibrosis 57 Malignant Melanoma 57 Fast Track Status 57 Xenograft 57 DUROS 57 Sleep Disturbances 57 Neoadjuvant 57 Files Patent Application 57 Advanced Colorectal Cancer 57 Novel Vaccine 57 LibiGel ® 57 BiTE 57 Cancer Treatments 57 Companion Diagnostic 57 Clinical Study Shows 57 immatics 57 Prostate Cancer Patients 57 Chronic Sinusitis 57 Intravitreal 57 RECOTHROM R 57 Dapagliflozin 57 Demonstrates Statistically Significant 57 Rotavirus Vaccines 57 Novel Therapies 57 Mutagenesis 57 Anti Clotting Drug 57 Treatment Experienced 57 Omacetaxine 57 Soft Tissue Sarcoma 57 Vascular Disrupting Agent 57 Antiretroviral Therapy 57 Paroxysmal 57 Study Reinforces 57 Phase 1a clinical 57 Announce License Agreement 57 Potent Antiviral Activity 57 Diabetic Neuropathic Pain 57 Relapsed Refractory 57 antisense inhibitors 57 Serdolect ® 57 Granulocyte Colony Stimulating Factor 57 Helps Predict 57 Lung Cancer Vaccine 57 ESBA# 57 Hepatitis C Genotype 57 Valve Replacement 57 Transfection 57 Ofatumumab 57 Epithelium 57 Arthritis Drug 57 Acute Decompensated Heart Failure 57 Milestone Payment From 57 Estrogen Therapy 57 Files Investigational 57 Osteoarthritis Pain 57 Embolic Protection 57 Mylan Receives Approval 57 Receives FDA Clearance 57 Atypical Antipsychotic 57 Glucosamine Chondroitin 57 Bioral R 57 Refractory Angina 57 PHASE III 57 Cognitive Deficits 57 Smallpox Vaccine 57 Telatinib 57 Influenza Vaccine 57 MMR Vaccine 57 intracellular uptake 57 Dual Opioid TM 57 Cancer Vaccine 57 PHX# 57 Targeted Therapy 57 Hormone Receptor Positive 57 Chemotherapeutic 57 Endurant 57 Heart Failure Therapy 57 Romidepsin 57 BioElectronics Corporation Announces 56 Auto Injector 56 Oral Calcitonin 56 Sanvar 56 Adipose Derived Stem Cells 56 HyACT 56 Cholesterol Drug 56 ISTODAX ® 56 Zinc Finger Nuclease 56 Gene Mutation 56 Artery Disease 56 Campath alemtuzumab 56 Oral Interferon 56 TO AVOID PREGNANCY WHILE 56 Watchful Waiting 56 Structure Function 56 Pivotal Clinical Trial 56 Randomized Clinical Trials 56 Salivary 56 Antigen CEA 56 Effective Treatments 56 Treating Prostate Cancer 56 Adverse Outcomes 56 Nuclear Receptors 56 Acute Coronary Syndromes 56 Suppresses 56 Chronic Renal Failure 56 Motility 56 VIVITROL ® 56 BrachySil TM 56 Significantly Reduces 56 Potelligent Technology 56 Aortic Valve 56 Immunologic 56 Diabetic Macular Edema 56 Organ Rejection 56 docetaxel Taxotere ® 56 Targeted Therapies 56 NICE Recommends 56 adult mesenchymal stem 56 Tolerability 56 Spiegelmer 56 Diabetic Ulcers 56 Metabolic Disorder 56 Breast Density 56 Amino Acid 56 Small Molecule Inhibitors 56 Prognostic Factors 56 Oral Fluid 56 Positive Opinion 56 Systolic Blood Pressure 56 HCl Tablets 56 Weight Loss Drug 56 Olmesartan 56 Drug Eluting Coronary Stent 56 Contrast Agents 56 Treatment Naïve Patients 56 Tesetaxel 56 Deforolimus 56 Glaucoma Treatment 56 Randomized Phase II 56 Remission Maintenance 56 Pivotal Phase II 56 Multiple Ascending Dose 56 Carotid Stent 56 Uterine Fibroid Embolization 56 Elderly Patients 56 DermaPrep 56 Technosphere ® 56 Endothelial Cells 56 mechanical thrombectomy 56 Micromet BiTE 56 Clinical Trial 56 Antimalarial 56 Fibroblast Growth Factor 56 Long Term Outcomes 56 Triglide 56 Immunogenicity 56 Patients Enrolled 56 miRview meso 56 Enhanze Technology 56 Treat Anemia 56 epoetin alpha 56 Impairs 56 Transfection Reagent 56 Adjuvant 56 GRAS Status 56 Licenses Novel 56 Novel Small Molecule 56 plasmid DNA vaccine 56 Hemodialysis Patients 56 BrachySil ™ 56 Collaborators Present 56 AMCIS 56 Announces Poster Presentations 56 Cyclophosphamide 56 Bipolar Depression 56 Genetic Mutation 56 Lyophilized 56 alpha1 proteinase inhibitor 56 Highly Accurate 56 Controlled Trial 56 macrolide antibiotics 56 Novel Treatments 56 HDL Selective Delipidation 56 Abacavir Sulfate 56 vivo validation 56 Lifestyle Intervention 56 Orphan Status 56 treat chronic sinusitis 56 Circ Pharma 56 Nuclear Receptor 56 Muscle Wasting 56 HuMax TAC 56 immune modulatory 56 Hospitalized Patients 56 Showed Significant 56 Advanced Ovarian Cancer 56 Transdermal System 56 parenterally administered 56 steroid dexamethasone 56 Induces 56 Virtual Histology 56 Aridol TM 56 Insulin Pen 56 Alpha lipoic acid 56 OHR/AVR# 56 Egg Freezing 56 Acute Myocardial Infarction 56 Aviptadil 56 Cervical Cancer Vaccine 56 Endocrine Therapy 56 Genetic Predisposition 56 ImmuKnow R 56 Genes Linked 56 Prolongs Life 56 Ligands 56 Protein Crystallography 56 Androgen Independent 56 Prospective Multicenter 56 Early Diagnosis 56 Virtual Colonoscopy 56 Gene Silencing 56 Fewer Side Effects 56 Potency 56 Neuroprotective Effects 56 Randomised Controlled Trial 56 Personalized Immunotherapy 56 Therapeutic Targets 56 LANTUS ® 56 patented Bioral